Literature DB >> 23748361

Ablation of the androgen receptor gene modulates atrial electrophysiology and arrhythmogenesis with calcium protein dysregulation.

Wen-Chin Tsai1, Liang-Yo Yang, Yao-Chang Chen, Yu-Hsun Kao, Yung-Kuo Lin, Shih-Ann Chen, Ching-Feng Cheng, Yi-Jen Chen.   

Abstract

Androgen deficiency is important in the pathophysiology of atrial fibrillation. Androgen regulates cardiac electrophysiology and calcium (Ca(2+)) homeostasis. The purpose of this study is to evaluate whether androgen receptor knockout (ARKO) can modulate atrial electrophysiology and arrhythmogenesis with modulation of Ca(2+) homeostasis proteins. We used conventional microelectrodes to study the action potential (AP) in left atrium (LA) tissues prepared from wild-type (WT) and ARKO mice (aged 6-10 months) before and after the administration of isoproterenol, hypocalcemic/hypercalcemic solutions, and ouabain. Echocardiography and Western blots were used to evaluate the cardiac function and expression levels of ionic channel proteins in WT and ARKO LAs. ARKO LAs had larger LA diameter with decreased LA fractional shortening than did WT LAs. In the current study, we found that ARKO LAs had a lower negative resting membrane potential and a greater 90% AP duration (APD) than did WT LAs. Isoproterenol increased the incidence and amplitude of delayed afterdepolarizations (DADs) in ARKO LAs but not in WT LAs. Hypocalcemic solutions prolonged APD in WT and ARKO LAs but increased DAD amplitude only in ARKO LAs. Hypercalcemic solutions shortened APD in ARKO LAs but not in WT LAs. Ouabain increased DAD amplitude in ARKO LAs but not in WT LAs. ARKO LAs expressed higher amounts of Ca(2+)/calmodulin-dependent protein kinase II, Na(+)/Ca(2+) exchanger, and phosphorylated phospholamban (Ser-16/Thr-17 site) and less Cav1.2, Kir2.1, Kir3.1, and Kv7.1 than WT LAs. These observations indicate that ARKO alters atrial electrophysiology with increased atrial arrhythmogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23748361     DOI: 10.1210/en.2012-2265

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Androgen receptor is expressed in mouse cardiomyocytes at prenatal and early postnatal developmental stages.

Authors:  Enrique Pedernera; María José Gómora; Iván Meneses; Marlon De Ita; Carmen Méndez
Journal:  BMC Physiol       Date:  2017-08-14

2.  Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes.

Authors:  Shih-Yu Huang; Yao-Chang Chen; Yu-Hsun Kao; Ming-Hsiung Hsieh; Yung-Kuo Lin; Cheng-Chih Chung; Ting-I Lee; Wen-Chin Tsai; Shih-Ann Chen; Yi-Jen Chen
Journal:  Oncotarget       Date:  2016-10-25

Review 3.  New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.

Authors:  Martin Aguilar; Robert A Rose; Abhijit Takawale; Stanley Nattel; Svetlana Reilly
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.